Warning: The NCBI web site requires JavaScript to function. more...
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.
Berry NB, Bapat SA.
J Ovarian Res. 2008 Nov 24;1:8.
Related citations
Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, Zhang S, Fang F, Lan X, Li M, Kennedy B, Bigsby RM, Huang TH, Nephew KP.
Epigenetics. 2010 Nov-Dec;5(8):716-29. Epub 2010 Nov 1.
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.
Breast Cancer Res. 2008;10(4):R62. Epub 2008 Jul 18.
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK.
Oncogene. 2009 Jan 15;28(2):209-18. Epub 2008 Oct 6.
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.
Ahmed N, Abubaker K, Findlay J, Quinn M.
Curr Cancer Drug Targets. 2010 May;10(3):268-78. Review.
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP, Beland FA, Pogribny IP.
Int J Cancer. 2010 Jun 1;126(11):2575-83.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Epigenetic regulation of cancer-associated genes in ovarian cancer.
Kwon MJ, Shin YK.
Int J Mol Sci. 2011 Jan 31;12(2):983-1008.
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK.
Carcinogenesis. 2010 Jun;31(6):974-83. Epub 2010 Jan 6.
Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells.
Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA.
Stem Cells. 2009 Sep;27(9):2059-68.
EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells.
Tellez CS, Juri DE, Do K, Bernauer AM, Thomas CL, Damiani LA, Tessema M, Leng S, Belinsky SA.
Cancer Res. 2011 Apr 15;71(8):3087-97. Epub 2011 Mar 1.
Oncogenic RAS alters the global and gene-specific histone modification pattern during epithelial-mesenchymal transition in colorectal carcinoma cells.
Peláez IM, Kalogeropoulou M, Ferraro A, Voulgari A, Pankotai T, Boros I, Pintzas A.
Int J Biochem Cell Biol. 2010 Jun;42(6):911-20. Epub 2010 Jan 28.
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.
Cancer Res. 2003 Jul 15;63(14):4174-80.
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
Su HY, Lai HC, Lin YW, Liu CY, Chen CK, Chou YC, Lin SP, Lin WC, Lee HY, Yu MH.
Int J Cancer. 2010 Aug 1;127(3):555-67.
Epigenetic signatures associated with different levels of differentiation potential in human stem cells.
Aranda P, Agirre X, Ballestar E, Andreu EJ, Román-Gómez J, Prieto I, Martín-Subero JI, Cigudosa JC, Siebert R, Esteller M, Prosper F.
PLoS One. 2009 Nov 13;4(11):e7809.
The epigenome as a therapeutic target in prostate cancer.
Perry AS, Watson RW, Lawler M, Hollywood D.
Nat Rev Urol. 2010 Dec;7(12):668-80. Epub 2010 Nov 9. Review.
Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
McGarvey KM, Van Neste L, Cope L, Ohm JE, Herman JG, Van Criekinge W, Schuebel KE, Baylin SB.
Cancer Res. 2008 Jul 15;68(14):5753-9.
Epigenetic gene regulation in stem cells and correlation to cancer.
Mathews LA, Crea F, Farrar WL.
Differentiation. 2009 Jul;78(1):1-17. Epub 2009 May 14. Review.
Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?
Scheel C, Weinberg RA.
Int J Cancer. 2011 Nov 15;129(10):2310-4. doi: 10.1002/ijc.26311. Epub 2011 Aug 29.
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, Kalland KH.
PLoS One. 2009;4(3):e4687. Epub 2009 Mar 5.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on